PLK1 and esophageal squamous cell carcinoma: In addition, in esophageal squamous cell carcinoma (ESCC), TFAP2C promotes the cell cycle, where TFAP2C activates the expression of polo-like kinase 1 (PLK1) by interacting with hematological and neurological expressed 1 like (HN1L) [94].